Cannabis Market Potential Soars, Investment Opportunities Emerge
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 31 minutes ago
0mins
Source: Fool
- Optimistic Market Outlook: According to estimates from Fortune Business Insights, the global cannabis market could exceed $1.4 trillion by 2034, up from $138 billion this year, reflecting a significant growth potential with a compound annual growth rate exceeding 34%.
- Policy Changes Impact: The recent rescheduling of FDA-approved marijuana products from Schedule I to Schedule III in the U.S. marks a significant milestone that could pave the way for future legalization, although no clear timeline exists yet, the government's consideration of marijuana benefits is a positive sign.
- Investment Risks and Opportunities: Investing in cannabis stocks like Tilray Brands carries risks due to its frequent losses and cash burn, but its stock often surges during discussions of legalization, attracting growth-oriented investors looking for significant gains.
- Advantages of Multi-State Operators: In addition to Tilray, multi-state operators such as Curaleaf Holdings and Trulieve Cannabis may benefit more directly from the rescheduling of marijuana in the U.S., making their market positions and potential returns important considerations for investors.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy TLRY?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on TLRY
Wall Street analysts forecast TLRY stock price to rise
4 Analyst Rating
1 Buy
3 Hold
0 Sell
Hold
Current: 5.460
Low
8.50
Averages
9.57
High
10.00
Current: 5.460
Low
8.50
Averages
9.57
High
10.00
About TLRY
Tilray Brands, Inc. is a lifestyle consumer products company, which focuses on providing research-backed medical cannabis products to physicians, pharmacies, and patients around the world. The Company operates in four segments, which include cannabis operations, which encompasses the production, distribution, sale, co-manufacturing, and advisory services of both medical and adult-use cannabis. Beverage operations, which encompasses the production, marketing, and sale of beverage products. Distribution operations, which encompasses the purchase and resale of pharmaceutical products to customers, and Wellness products, which encompasses wellness and better-for-you foods and beverages. It offers a portfolio of brands and products across medical and adult-use cannabis, craft beer, spirits, beverages, and hemp foods. Its adult-use portfolio offers a range of products, from flowers to beverages. Its beverage-alcohol portfolio includes a selection of craft beer, spirits, and beverages.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Optimistic Market Outlook: According to estimates from Fortune Business Insights, the global cannabis market could exceed $1.4 trillion by 2034, up from $138 billion this year, reflecting a significant growth potential with a compound annual growth rate exceeding 34%.
- Policy Changes Impact: The recent rescheduling of FDA-approved marijuana products from Schedule I to Schedule III in the U.S. marks a significant milestone that could pave the way for future legalization, although no clear timeline exists yet, the government's consideration of marijuana benefits is a positive sign.
- Investment Risks and Opportunities: Investing in cannabis stocks like Tilray Brands carries risks due to its frequent losses and cash burn, but its stock often surges during discussions of legalization, attracting growth-oriented investors looking for significant gains.
- Advantages of Multi-State Operators: In addition to Tilray, multi-state operators such as Curaleaf Holdings and Trulieve Cannabis may benefit more directly from the rescheduling of marijuana in the U.S., making their market positions and potential returns important considerations for investors.
See More
- Regulatory Milestone: The U.S. government's rescheduling of certain marijuana products from Schedule I to Schedule III marks a significant milestone for the cannabis industry, potentially paving the way for future legalization, although further reforms are still needed.
- Market Potential: According to estimates from Fortune Business Insights, the global cannabis market could exceed $1.4 trillion by 2034, up from $138 billion this year, reflecting a compounded annual growth rate of over 34%, highlighting substantial investment opportunities.
- Investment Risks and Opportunities: While cannabis stocks like Tilray Brands carry risks of losses, their values often surge during legalization discussions, attracting long-term growth investors, especially against the backdrop of high valuations in tech stocks.
- Diversified Investment Strategy: In addition to Tilray, multi-state operators like Curaleaf Holdings and Trulieve Cannabis may benefit more directly from marijuana rescheduling in the U.S., prompting investors to carefully assess risks and potential returns.
See More
- Ongoing Losses: Canopy Growth has faced years of net losses, with its latest quarterly report showing revenue of C$54.5 million and a net loss of nearly C$45.8 million, indicating persistent struggles with profitability that have severely impacted investor sentiment.
- Dilutive Share Issuance: The company has repeatedly attempted to shore up its finances through dilutive secondary share issues, which have diluted existing shareholders' stakes and driven away potential investors, negatively affecting stock performance.
- Acquisition of MTL Cannabis: Canopy Growth completed its acquisition of MTL Cannabis in March for C$125 million, and while MTL has posted some profits in the past four quarters, the deal is unlikely to significantly improve Canopy's financial situation, failing to fundamentally alter its financial struggles.
- Market Environment Challenges: Regulatory bottlenecks in Canada and competition from gray and black markets continue to hinder market development, and despite the U.S. market's potential, legal uncertainties and fierce domestic competition pose significant challenges for Canopy Growth in achieving growth.
See More
- Stock Decline: Canopy Growth's stock has dropped over 12% since the beginning of May, contrasting with the nearly 2% gain of the S&P 500, indicating a pessimistic investor sentiment that could lead to further capital outflows.
- Financial Struggles: The company's latest quarterly revenue was C$54.5 million, with a net loss nearing C$45.8 million; although the loss has narrowed, ongoing financial pressures raise doubts about future profitability, potentially leading to more dilutive share issues.
- MTL Cannabis Acquisition: Canopy Growth completed its acquisition of MTL Cannabis in March for C$125 million (US$91 million), and while MTL has reported profits in the past four quarters, its revenue is unlikely to significantly improve Canopy's overall financial situation, failing to change the long-term loss trajectory.
- Market Challenges: Regulatory bottlenecks in Canada and competition from the black market continue to hinder Canopy Growth's growth potential, while slow legal reforms in the U.S. present significant challenges in both markets, suggesting the need for further dilutive financing to sustain operations.
See More
- Post-Merger Market Performance: Tilray merged with Aphria in 2021 to create a global cannabis leader, yet five years later, its stock has plummeted over 96%, indicating that the merger has not achieved the expected market growth.
- Revenue Volatility and Profitability Challenges: Although Tilray's revenue has increased in recent years, the persistent lack of profitability and market challenges have left investors concerned about its future profit trajectory, especially with the U.S. market remaining inaccessible.
- Expansion into Beverage Sector: Tilray has diversified by acquiring brewing companies, with beverages now accounting for about a quarter of its total revenue; however, this strategy has not effectively improved overall profitability and has instead increased financial pressure on the company.
- Investment Risks and Market Outlook: Tilray's stock has dropped 38% this year, lacking clear growth catalysts, and while its valuation has significantly declined, investors should remain cautious due to the high-risk nature of this stock, making it unsuitable for long-term investment.
See More
- Price Volatility: Tilray Brands' stock surged recently due to U.S. legalization catalysts but subsequently fell below $6 from nearly $8 as investors reassessed the details, indicating market caution regarding short-term prospects.
- Analyst Rating Upgrade: Following Tilray's latest quarterly earnings release, Roth Capital's William Kirk upgraded the stock from 'neutral' to 'buy' while maintaining a $10 price target, reflecting optimism about the stock's future.
- International Market Growth: Tilray's international cannabis sales grew 73% year-over-year, demonstrating the company's successful penetration into markets outside North America, which may support future revenue growth.
- Domestic Market Pressure: The ability of Canadian companies to export products has alleviated price pressure in the domestic market; however, Tilray's beverage unit is experiencing declining revenue and gross profits, and the company continues to report a net loss, highlighting ongoing challenges.
See More











